Opportunities span NGS, liquid biopsy, multi-omics and AI diagnostics; companion tests for targeted therapies and immuno-oncology; and biomarker-led trialsDublin, July 22, 2026 (GLOBE NEWSWIRE) -- The ...

Recently validated markers have helped improve treatment but more are needed ...

Biomarker testing in colorectal cancer (CRC) informs doctors about unique features of cancer that may influence its growth, spread, recurrence, and treatment response. Colorectal cancer (CRC), which ...

Opportunities span minimally invasive early cancer detection, real-time treatment and recurrence monitoring, NGS and digital PCR assays, AI-enabled bioinformatics, and exosome biomarkers. Hospitals, ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

Despite significant advancements in medicine, cancer remains a major health challenge and the leading cause of mortality worldwide, highlighting the urgent need for continued research to identify ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

Even as biomarker testing has become increasingly important for selecting the right lung cancer treatment, the time it takes to order these tests hasn't improved. Overall, the time from biopsy to ...

Cancer biomarkers span a broad biological spectrum, including proteins, metabolites, and nucleic acids detectable in samples such as tissue biopsies and blood. 1 At the beginning of a biomarker ...

The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing PC at an earlier stage. Pancreatic cancer (PC) is the worst prognosis cancer ...

Obstacles to free, essential biomarker testing remain as reimbursement negotiations begin, and eligibility criteria require ...